Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : A US National Health Care System? -- Ignore unavailable to you. Want to Upgrade?

To: Peter Dierks who wrote (1166)	4/24/2006 7:17:17 AM
From: Lady Lurksalot	Respond to of 42652

Peter, No, kidney recipients do indeed take anti-rejection medications and are by no means less susceptible to complications. Many kidneys are rejected and more than once in the same patient. The only thing simpler about kidney transplantation is that the kidney donor does not have to be dead. This explains the prevalance of a black to grey market for kidneys. It is not difficult for a physician to determine from whence a patient has received transplantation. Most patients will stay with one physician or group of physicians from start to finish and do not go traipsing all over the world from doctor to doctor or hospital to hospital. There is always that pesky chain of evidence, so to speak. For any number of reasons, many doctors refuse to treat patients who receive transplants from vague sources, not the least among which is the increased incidence of postoperative complications and the inherent liability to the current treating physician(s). Some physicians also will refuse to treat such patients on moral/ethical grounds. - Holly